Stay updated with breaking news from Array Biopharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With its purchase of Washington-based Seagen, Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
The pharmaceutical giant said it will pay $229 in cash for each Seagen share.
Pfizer is spending about $43 billion to reach deeper into new cancer treatments that target tumor cells while sparing surrounding healthy tissue.
The pharmaceutical giant said it will pay $229 in cash for each Seagen share.
/PRNewswire/ -- The "Colorectal Cancer Drugs Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...